All Articles

Vancouver-based intimate apparel brand Huha secures record-breaking investment, fueled by demand for health-focused and sustainable underwear. Experts say the deal validates a growing trend.

A critical antifungal drug, Flucytosine, faces escalating demand fueled by increasing fungal disease prevalence & limited treatment options. Supply chain vulnerabilities & access challenges threaten vulnerable populations.

A new report reveals a widening gap in financial well-being for low-income Canadians, with rising debt and shrinking savings. Experts outline a roadmap for collaborative action to address this growing crisis.

Euro Tech Holdings secures a $2.1M contract to provide crucial water treatment solutions for a new Mongolian uranium mine, signaling a strategic move into emerging markets and a commitment to sustainable resource extraction.

GAC Toyota unveils the WILDLANDER & bZ7, showcasing advanced cockpit tech, HarmonyOS integration, and a commitment to both hybrid and all-electric vehicles tailored for the competitive Chinese market.

Global steel giant ArcelorMittal cancels nearly 78 million treasury shares, signaling confidence and a commitment to returning capital to investors. The move is expected to significantly impact earnings per share.

Shares in PayPoint saw a sharp decline following interim results, but key directors stepped in to buy. Is this a vote of confidence, a strategic move, or a response to market conditions? We delve into the details.

Hampton University's recent Carnegie R2 designation signals a new era for the HBCU, fueled by surging research funding, a growing economic impact, and a commitment to student success. This article explores the factors driving the university's ascent.

Chinese automaker GAC partners with Magna International to build EVs in Austria, aiming to disrupt the European market with competitive pricing and a growing presence. Is this the start of a new era for automotive manufacturing?

Sisram Medical’s launch of Universkin by Alma in Hong Kong signals a growing trend in AI-driven personalized skincare. Is this the future of beauty, or just another tech-driven fad? We investigate.

A new CDMO collaboration aims to streamline complex API development & manufacturing in India, leveraging a 'virtual' model and global regulatory expertise. This partnership signals a potential shift in pharmaceutical outsourcing.

Automotive diagnostic specialist ANCEL is showcasing its latest 'Professional Auto Service Solutions' at Automechanika Shanghai, aiming to bridge the gap between DIY and pro repairs with advanced tools and a focus on China’s booming aftermarket.

New servo drive lines from Elmo Motion Control push the boundaries of compactness and integrated safety, addressing the growing demand for efficient, resilient automation across key industries.

A stalled investment from Turkish tourism giant Neset Kockar and growing regulatory scrutiny are casting a shadow over the future of leading Baltic tour operator Novaturas.

NB Private Equity Partners’ recent share repurchase program, coupled with strong NAV performance, suggests a bullish outlook despite broader market discounts for listed private equity firms. A closer look at the firm's strategy and Neuberger Berman’s influence.

Canadian firm E3 Lithium reports positive Q3 results, achieving 99.7% lithium carbonate purity and securing crucial funding and partnerships to bolster its sustainable extraction process.

Canadian VC firm Inovia Capital expands into Abu Dhabi, aiming to bolster AI & digital infrastructure collaboration and capitalize on growing investment opportunities in the Gulf region.

Xi’an Film Studio launches what it claims is the world’s first XR cinema, blending cutting-edge VR technology with cinematic storytelling. Could this revolutionize how we experience movies?

Chinese automaker GAC is partnering with Magna International to assemble EVs in Austria, signaling a shift towards contract manufacturing and a more agile approach to international expansion. This move could reshape the global automotive landscape.

Innovent Biologics' Xinermei (mazdutide) has become the first locally developed obesity drug approved in China, potentially reshaping the market and offering a new treatment option for a growing health crisis.